feed,title,long_url,short_url
Benzinga,"Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder",https://benzinga.com/general/biotech/22/08/28583638/travere-csls-sparsentan-application-in-european-review-for-rare-kidney-disorder,https://bit.ly/3PG4l8k
Benzinga,Novo Nordisk's Subcutaneous Semaglutide Shows Positive Action In Type 2 Diabetes,https://benzinga.com/general/biotech/22/08/28583373/novo-nordisks-subcutaneous-semaglutide-shows-positive-action-in-type-2-diabetes,https://bit.ly/3QHPCex
Benzinga,Teleflex Beefs Up Its Bariatric Surgery Portfolio With This $170M Acquisition,https://benzinga.com/news/earnings/22/08/28583081/teleflex-beefs-up-its-bariatric-surgery-portfolio-with-this-170m-acquisition,https://bit.ly/3T73qAP
